Yüklüyor......
Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis
AIMS: The purpose was to determine the exposure−response relationship of everolimus in patients with angiomyolipoma from the EXIST‐2 trial and to analyze the correlation between exposure and plasma concentrations of angiogenic biomarkers in these patients. METHODS: One hundred and eighteen patients...
Kaydedildi:
| Yayımlandı: | Br J Clin Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4834586/ https://ncbi.nlm.nih.gov/pubmed/26580489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12834 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|